Russell Barton - Net Worth and Insider Trading
Russell Barton Net Worth
The estimated net worth of Russell Barton is at least $259,604 dollars as of 2024-11-13. Russell Barton is the COO of Acumen Pharmaceuticals Inc and owns about 96,867 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $259,604. Details can be seen in Russell Barton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Russell Barton has not made any transactions after 2024-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Russell Barton
Russell Barton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Russell Barton owns 1 companies in total, including Acumen Pharmaceuticals Inc (ABOS) .
Click here to see the complete history of Russell Barton’s form 4 insider trades.
Insider Ownership Summary of Russell Barton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 2024-01-18 | Chief Operating Officer |
Russell Barton Latest Holdings Summary
Russell Barton currently owns a total of 1 stock. Russell Barton owns 96,867 shares of Acumen Pharmaceuticals Inc (ABOS) as of January 18, 2024, with a value of $259,604.
Latest Holdings of Russell Barton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals Inc | 2024-01-18 | 96,867 | 2.68 | 259,604 |
Holding Weightings of Russell Barton
Russell Barton Form 4 Trading Tracker
According to the SEC Form 4 filings, Russell Barton has made a total of 1 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the sale of 2,833 shares on January 18, 2024, which brought Russell Barton around $10,567.
Insider Trading History of Russell Barton
- 1
Russell Barton Trading Performance
Russell Barton Ownership Network
Ownership Network List of Russell Barton
Ownership Network Relation of Russell Barton
Russell Barton Owned Company Details
What does Acumen Pharmaceuticals Inc do?
Who are the key executives at Acumen Pharmaceuticals Inc?
Russell Barton is the Chief Operating Officer of Acumen Pharmaceuticals Inc. Other key executives at Acumen Pharmaceuticals Inc include Chief Legal Office & Corp Sec Derek M Meisner , director & President and CEO Daniel Joseph Oconnell , and Chief Financial Officer Matt Zuga .
Acumen Pharmaceuticals Inc (ABOS) Insider Trades Summary
Over the past 18 months, Russell Barton made 1 insider transaction in Acumen Pharmaceuticals Inc (ABOS) with a net sale of 2,833. Other recent insider transactions involving Acumen Pharmaceuticals Inc (ABOS) include a net purchase of 5,161,290 shares made by Ra Capital Healthcare Fund Lp , a net sale of 41,949 shares made by Jeffrey L. Ives , and a net sale of 15,200 shares made by Daniel Joseph Oconnell .
In summary, during the past 3 months, insiders sold 0 shares of Acumen Pharmaceuticals Inc (ABOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 76,281 shares of Acumen Pharmaceuticals Inc (ABOS) were sold and 5,161,290 shares were bought by its insiders, resulting in a net purchase of 5,085,009 shares.
Acumen Pharmaceuticals Inc (ABOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acumen Pharmaceuticals Inc Insider Transactions
Russell Barton Mailing Address
Above is the net worth, insider trading, and ownership report for Russell Barton. You might contact Russell Barton via mailing address: C/o Acumen Pharmaceuticals, Inc., 427 Park Street, Charlottesville Va 22902.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
